��������

Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumo... Read more